Total Payments
$964.57
2020 Payments
$123.06
Companies
19
Transactions
51
Medicare Patients
5,469
Medicare Billing
$442,402
Payment Breakdown by Category
Food & Beverage$959.57 (99.5%)
Education$5.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $959.57 | 50 | 99.5% |
| Education | $5.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $195.30 | 8 | $0 (2018) |
| Optinose US, Inc. | $123.06 | 1 | $0 (2020) |
| Amgen Inc. | $95.91 | 5 | $0 (2018) |
| Novo Nordisk Inc | $74.51 | 5 | $0 (2018) |
| GlaxoSmithKline, LLC. | $65.21 | 5 | $0 (2018) |
| Allergan Inc. | $56.19 | 4 | $0 (2017) |
| PFIZER INC. | $55.75 | 3 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.60 | 3 | $0 (2018) |
| Shire North American Group Inc | $39.50 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $35.59 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $123.06 | 1 | Optinose US, Inc. ($123.06) |
| 2018 | $404.07 | 25 | Amgen Inc. ($66.14) |
| 2017 | $437.44 | 25 | AstraZeneca Pharmaceuticals LP ($156.90) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/24/2020 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $123.06 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/17/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/11/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Neuroscience | ||||||
| 11/19/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: DIABETES | ||||||
| 11/12/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 11/05/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Neuroscience | ||||||
| 10/16/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/23/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 07/09/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: DIABETES | ||||||
| 06/18/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: DIABETES | ||||||
| 06/06/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.64 | General |
| 05/14/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Respiratory | ||||||
| 05/08/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/30/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Diabetes | ||||||
| 04/23/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, BELSOMRA | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/10/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2018 | AKRIMAX PHARMACEUTICALS, LLC | Stendra (Drug) | Food and Beverage | Cash or cash equivalent | $11.94 | General |
| Category: Erectile Dysfunction | ||||||
| 03/19/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Cardiovascular | ||||||
| 03/06/2018 | Noden Pharma USA Inc | TEKTURNA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Hypertension | ||||||
| 02/20/2018 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Endocrinology | ||||||
| 02/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/05/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Central Nervous System (CNS) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,464 | 2,099 | $312,261 | $119,969 |
| 2022 | 17 | 1,342 | 2,019 | $315,934 | $113,950 |
| 2021 | 16 | 1,283 | 1,972 | $287,290 | $106,675 |
| 2020 | 18 | 1,380 | 2,142 | $250,269 | $101,809 |
Total Patients
5,469
Total Services
8,232
Medicare Billing
$442,402
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 340 | 641 | $156,404 | $51,798 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 147 | 147 | $36,309 | $18,211 | 50.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 48 | 48 | $27,306 | $13,472 | 49.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 80 | 101 | $34,542 | $12,043 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 122 | $20,984 | $6,444 | 30.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 56 | 57 | $7,899 | $4,070 | 51.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 485 | 702 | $4,212 | $4,064 | 96.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 14 | $7,378 | $2,983 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,314 | $2,520 | 34.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 57 | $3,447 | $1,699 | 49.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 47 | 47 | $2,750 | $1,401 | 50.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 19 | $2,583 | $946.28 | 36.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 24 | $648.00 | $244.42 | 37.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 97 | $485.00 | $74.84 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 343 | 685 | $173,443 | $53,758 | 31.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 110 | 144 | $49,912 | $17,738 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 118 | 118 | $30,460 | $14,891 | 48.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 25 | 25 | $14,175 | $6,951 | 49.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 64 | 67 | $8,741 | $4,562 | 52.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 18 | 18 | $5,940 | $2,756 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $7,591 | $2,501 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 37 | $6,626 | $2,429 | 36.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 66 | 69 | $4,014 | $1,972 | 49.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $4,014 | $1,723 | 42.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 397 | 579 | $3,474 | $1,706 | 49.1% |
About Dr. Jerome Rubbelke, M.D
Dr. Jerome Rubbelke, M.D is a Family Medicine healthcare provider based in Buena Vista, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164415113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerome Rubbelke, M.D has received a total of $964.57 in payments from pharmaceutical and medical device companies, with $123.06 received in 2020. These payments were reported across 51 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($959.57).
As a Medicare-enrolled provider, Rubbelke has provided services to 5,469 Medicare beneficiaries, totaling 8,232 services with total Medicare billing of $442,402. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Buena Vista, VA
- Active Since 08/24/2005
- Last Updated 12/22/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164415113
Products in Payments
- FARXIGA (Drug) $183.85
- Xhance (Drug) $123.06
- Trintellix (Drug) $48.54
- Aimovig (Biological) $46.87
- JARDIANCE (Drug) $42.60
- VYVANSE (Drug) $39.50
- JANUVIA (Drug) $35.59
- Repatha (Biological) $34.04
- Victoza (Drug) $32.22
- ELIQUIS (Drug) $30.57
- XARELTO (Drug) $29.88
- LINZESS (Drug) $25.45
- VIAGRA (Drug) $21.12
- TEKTURNA (Drug) $18.94
- CHANTIX (Drug) $17.96
- VRAYLAR (Drug) $17.05
- LYRICA (Drug) $16.67
- Androgel (Drug) $15.61
- BREO (Drug) $15.37
- Prolia (Biological) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Buena Vista
Erica Smith, Do, DO
Family Medicine — Payments: $898.56
Family Medicine $898.56
Claire Wallace, M.d, M.D
Family Medicine — Payments: $315.00
Family Medicine $315.00
Thomas White, M.d, M.D
Family Medicine — Payments: $280.20
Family Medicine $280.20
Craig Otteni, Md, MD
Family Medicine — Payments: $151.59
Family Medicine $151.59
Barbara Trandel, Md, MD
Family Medicine — Payments: $146.24
Family Medicine $146.24
David Stuart, Md, MD
Family Medicine — Payments: $136.41
Family Medicine $136.41